Literature DB >> 9585616

An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation.

D Bodmer1, M J Eleveld, M J Ligtenberg, M A Weterman, B A Janssen, D F Smeets, P E de Wit, A van den Berg, E van den Berg, M I Koolen, A Geurts van Kessel.   

Abstract

Through allele-segregation and loss-of-heterozygosity analyses, we demonstrated loss of the translocation-derivative chromosome 3 in five independent renal cell tumors of the clear-cell type, obtained from three members of a family in which a constitutional t(2;3)(q35;q21) was encountered. In addition, analysis of the von Hippel-Lindau gene, VHL, revealed distinct insertion, deletion, and substitution mutations in four of the five tumors tested. On the basis of these results, we conclude that, in this familial case, an alternative route for renal cell carcinoma development is implied. In contrast to the first hit in the generally accepted two-hit tumor-suppressor model proposed by Knudson, the familial translocation in this case may act as a primary oncogenic event leading to (nondisjunctional) loss of the der(3) chromosome harboring the VHL tumor-suppressor gene. The risk of developing renal cell cancer may be correlated directly with the extent of somatic (kidney) mosaicism resulting from this loss.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585616      PMCID: PMC1377167          DOI: 10.1086/301888

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  35 in total

1.  Report and abstracts of the fifth international workshop on human chromosome 3 mapping 1994. Ann Arbor, Michigan, May 8-9, 1994.

Authors:  D I Smith; T W Glover; R Gemmill; H Drabkin; P O'Connell; S L Naylor
Journal:  Cytogenet Cell Genet       Date:  1995

2.  Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation.

Authors:  L Schmidt; F Li; R S Brown; S Berg; F Chen; M H Wei; K Tory; I Lerman; B Zbar
Journal:  Cancer J Sci Am       Date:  1995 Sep-Oct

3.  Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.

Authors:  T Shuin; K Kondo; S Torigoe; T Kishida; Y Kubota; M Hosaka; Y Nagashima; H Kitamura; F Latif; B Zbar
Journal:  Cancer Res       Date:  1994-06-01       Impact factor: 12.701

4.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

Authors:  J G Herman; F Latif; Y Weng; M I Lerman; B Zbar; S Liu; D Samid; D S Duan; J R Gnarra; W M Linehan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 5.  Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis.

Authors:  J R Gnarra; M I Lerman; B Zbar; W M Linehan
Journal:  Semin Oncol       Date:  1995-02       Impact factor: 4.929

6.  Familial and sporadic human renal cell carcinoma: evidence against a double-loss mechanism of carcinogenesis.

Authors:  W D Stein; A D Stein
Journal:  J Clin Epidemiol       Date:  1995-06       Impact factor: 6.437

7.  The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers.

Authors:  M Ohta; H Inoue; M G Cotticelli; K Kastury; R Baffa; J Palazzo; Z Siprashvili; M Mori; P McCue; T Druck; C M Croce; K Huebner
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

8.  Mutations of the VHL tumour suppressor gene in renal carcinoma.

Authors:  J R Gnarra; K Tory; Y Weng; L Schmidt; M H Wei; H Li; F Latif; S Liu; F Chen; F M Duh
Journal:  Nat Genet       Date:  1994-05       Impact factor: 38.330

9.  Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma.

Authors:  K Foster; A Prowse; A van den Berg; S Fleming; M M Hulsbeek; P A Crossey; F M Richards; P Cairns; N A Affara; M A Ferguson-Smith
Journal:  Hum Mol Genet       Date:  1994-12       Impact factor: 6.150

Review 10.  Antioncogenes and human cancer.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

View more
  13 in total

1.  Case report: renal cell carcinoma segregating with a t(2;3)(q37.3;q13.2) chromosomal translocation in an Ashkenazi Jewish family.

Authors:  L McKay; M Frydenberg; L Lipton; F Norris; I Winship
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

2.  Characterization of a 3;6 translocation associated with renal cell carcinoma.

Authors:  Rebecca E Foster; Mahera Abdulrahman; Mark R Morris; Elena Prigmore; Susan Gribble; Beeling Ng; Dean Gentle; Steven Ready; Phil M T Weston; Michael S Wiesener; Takeshi Kishida; Masahiro Yao; Val Davison; Jose Luis Barbero; Carol Chu; Nigel P Carter; Farida Latif; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

3.  Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.

Authors:  H Kanayama ; W O Lui; M Takahashi; T Naroda; D Kedra; F K Wong; Y Kuroki; Y Nakahori; C Larsson; S Kagawa; B T Teh
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

Review 4.  Familial adult renal neoplasia.

Authors:  M Takahashi; R Kahnoski; D Gross; D Nicol; B T Teh
Journal:  J Med Genet       Date:  2002-01       Impact factor: 6.318

5.  Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.

Authors:  E R Woodward; S C Clifford; D Astuti; N A Affara; E R Maher
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

Review 6.  The Nephrologist's Tumor: Basic Biology and Management of Renal Cell Carcinoma.

Authors:  Susie L Hu; Anthony Chang; Mark A Perazella; Mark D Okusa; Edgar A Jaimes; Robert H Weiss
Journal:  J Am Soc Nephrol       Date:  2016-03-09       Impact factor: 10.121

7.  Nuclear Pedigree Criteria for the Identification of Individuals Suspected to be at Risk of an Inherited Predisposition to Renal Cancer.

Authors:  Aleksandra Tołoczko-Grabarek; Andrzej Sikorski; Marek Brzosko; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2005-08-15       Impact factor: 2.857

Review 8.  Renal cancer in von Hippel-Lindau disease and related syndromes.

Authors:  Birke Bausch; Cordula Jilg; Sven Gläsker; Alexander Vortmeyer; Niklas Lützen; Alexandra Anton; Charis Eng; Hartmut P H Neumann
Journal:  Nat Rev Nephrol       Date:  2013-07-30       Impact factor: 28.314

Review 9.  Origin of renal cell carcinomas.

Authors:  Manuel Valladares Ayerbes; Guadalupe Aparicio Gallego; Silvia Díaz Prado; Paula Jiménez Fonseca; Rosario García Campelo; Luis Miguel Antón Aparicio
Journal:  Clin Transl Oncol       Date:  2008-11       Impact factor: 3.405

Review 10.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.